First, although the effectiveness of celecoxib in reducing AAA expression correlated with increased expression of the SMC differentiation marker α-actin, our findings have not confirmed a causative role for increased SMC differentiation as a mechanism contributing to the effectiveness of COX-2 inhibition. Here, PTGS2 is linked to triple-A syndrome.